Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor

By Thearle Marie  

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 418-424

Springer Publishing Company

Access to resources Recommend Favorite

ACTH and α-Subunit are Co-expressed in Rare Human Pituitary Corticotroph Cell Adenomas Proposed to Originate from ACTH-Committed Early Pituitary Progenitor Cells

By Suzuki Masanori   Egashira Noboru   Kajiya Hanako   Minematsu Takeo   Takekoshi Susumu   Tahara Shigeyuki   Sanno Naoko   Teramoto Akira   Osamura Robert  

Endocrine Pathology, Vol. 19, Iss. 1, 2008-04 ,pp. : 17-26

Humana Press, Inc

Access to resources Recommend Favorite

Corticotroph pituitary carcinoma: Case report and literature review

By Holthouse David   Robbins Peter   Kahler Richard   Knuckey Neville   Pullan Peter  

Endocrine Pathology, Vol. 12, Iss. 3, 2001-09 ,pp. : 329-341

Humana Press, Inc

Access to resources Recommend Favorite

The History of the Treatment of Pituitary Adenomas

By Maartens Nicholas F.  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 9-26

Humana Press, Inc

Access to resources Recommend Favorite

CD markers in pituitary adenomas

By Saeger Wolfgang  

Endocrine Pathology, Vol. 12, Iss. 3, 2001-09 ,pp. : 307-313

Humana Press, Inc

Access to resources Recommend Favorite